United States
Premiumsupplier
lenvatinib mesylate CAS NO.857890-39-2
- Min.Order: 0
- Payment Terms:
- Product Details
Keywords
- 4-[3-Chloro-4-[(cyclopropylaminocarbonyl)amino]phenoxy]-7-methoxy-6-quinolinecarboxamide Mesylate
- E 7080 Mesylate
Quick Details
- ProName: lenvatinib mesylate
- CasNo: 857890-39-2
- Molecular Formula: C21H19ClN4O4.CH4O3S
- Appearance: White to Light Beige Solid
- Application: Antineoplastic Agents
- PackAge: 5 g
- Purity: ≥95%
- Storage: Store at -20°C
- LimitNum: 0
Superiority
We provide customized and high-quality lenvatinib mesylate product for your project.
Details
Lenvatinib is a receptor tyrosine kinase (RTK) inhibitor that has selectivity for VEGFR2. It exhibits antineoplastic activity, and has been indicated for the treatment of patients with locally recurrent or metastatic, progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer.
